跳转至内容
Merck
CN

主要文件

查看所有文档

40301

2-丙醇

别名:

IPA, 仲丙醇, 异丙醇

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:
(CH3)2CHOH
化学文摘社编号:
67-63-0
分子量:
60.10
EC Number:
200-661-7
UNSPSC Code:
12352300
PubChem Substance ID:
57649974
Beilstein/REAXYS Number:
635639
MDL number:
MFCD00011674
Bp:
82 °C (lit.)
Vapor pressure:
33 mmHg ( 20 °C), 44 mmHg ( 25 °C)
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

vapor density

2.1 (vs air)

vapor pressure

33 mmHg ( 20 °C), 44 mmHg ( 25 °C)

form

liquid

CofA

specification on request

autoignition temp.

750 °F

expl. lim.

2.0-12.7 %, 93 °C

color

colorless

refractive index

n20/D 1.377 (lit.), n/D

bp

82 °C (lit.)

mp

−89.5 °C (lit.)

solubility

water: soluble (completely)

density

0.785 g/mL at 25 °C (lit.)

SMILES string

CC(C)O

InChI

1S/C3H8O/c1-3(2)4/h3-4H,1-2H3

InChI key

KFZMGEQAYNKOFK-UHFFFAOYSA-N

Still not finding the right product?

Explore all of our products under 2-丙醇

pictograms

FlameExclamation mark
GHS02,GHS07

signalword

Danger

Hazard Classifications

Eye Irrit. 2 - Flam. Liq. 2 - STOT SE 3

target_organs

Respiratory system

存储类别

3 - Flammable liquids

wgk

WGK 1

flash_point_f

53.6 °F - closed cup

flash_point_c

12.0 °C - closed cup

ppe

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

法规信息

新产品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
SZBG167AV
SZBG053EV
SZBG015AV
SZBF309BV
SZBF155AV

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Peter C Grayson et al.
Arthritis & rheumatology (Hoboken, N.J.), 67(7), 1922-1932 (2015-04-22)
To discover biomarkers involved in the pathophysiology of antineutrophil cytoplasmic antibody-associated vasculitis (AAV) and to determine whether low-density granulocytes (LDGs) contribute to gene expression signatures in AAV. The source of clinical data and linked biologic specimens was a randomized controlled
Jan Rybniker et al.
Nature communications, 6, 7659-7659 (2015-07-15)
Better antibiotics capable of killing multi-drug-resistant Mycobacterium tuberculosis are urgently needed. Despite extensive drug discovery efforts, only a few promising candidates are on the horizon and alternative screening protocols are required. Here, by testing a panel of FDA-approved drugs in
H Dolatshad et al.
Leukemia, 29(5), 1092-1103 (2014-11-28)
The splicing factor SF3B1 is the most commonly mutated gene in the myelodysplastic syndrome (MDS), particularly in patients with refractory anemia with ring sideroblasts (RARS). We investigated the functional effects of SF3B1 disruption in myeloid cell lines: SF3B1 knockdown resulted
查看所有相关文献

全球贸易项目编号

货号GTIN
330590-5G04061826726099